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Abstract 
 
Common and complex traits are the consequence of the interaction and regulation of 
multiple genes simultaneously, which work in a coordinated way. However, the vast majority of 
studies focus on the differential expression of one individual gene at a time. Here, we aim to 
provide insight into the underlying relationships of the genes expressed in the human brain in cases 
with schizophrenia (SCZ) and controls. We introduced a novel approach to identify differential 
gene regulatory patterns and identify a set of essential genes in the brain tissue. Our method 
integrates genetic, transcriptomic, and Hi-C data and generates a transcriptomic-causal network. 
Employing this approach for analysis of RNA-seq data from CommonMind Consortium, we 
identified differential regulatory patterns for SCZ cases and control groups to unveil the 
mechanisms that control the transcription of the genes in the human brain. Our analysis identified 
modules with a high number of SCZ-associated genes as well as assessing the relationship of the 
hubs with their down-stream genes in both, cases and controls. In addition, the results identified 
essential genes for brain function and suggested new genes putatively related to SCZ.  
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Introduction 
Differences in gene expression are likely to underpin much of human diversity, including 
psychiatric disorders such as schizophrenia (SCZ). Schizophrenia is a severe, complex, and 
heritable psychiatric disorder with a world-wide prevalence of 1%, characterized by abnormalities 
in thought and cognition. Recent studies on SCZ, which comprise linkage scans and their meta-
analyses, candidate gene association analyses, differential expression analyses and genome-wide 
association studies (GWAS), have investigated genes/markers and chromosomal regions for SCZ 
(Ng et al., 2009; International Schizophrenia Consortium et al., 2009; Shi et al., 2009; Stefansson 
et al., 2009; Ripke et al., 2014). These studies show that SCZ disorder involves changes in multiple 
genes, each conferring small and incremental risk. The risks potentially converge in deregulated 
biological pathways, cellular functions and local circuit that eventually scale up to brain region 
pathophysiology (Belmaker and Agam, 2008; Sibille and French, 2013). Therefore, understanding 
the impact of these effects on pathophysiology of SCZ is essential to reveal their relationship as a 
system. However, typical methods for differential expression analysis are based on the analysis of 
a single gene at a time regardless of its relation with other genes.  
To divulge underlying relationships of genes related to SCZ, we focus on identifying 
transcriptomic causal networks in an observational study and introduce a novel approach 
established in Mendelian Randomization and Bayesian graphical modeling. This approach is an 
adaptation of the genome directed acyclic graph (G-DAG) algorithm (Yazdani et al., 2016) for 
transcriptomic networks, which was originally proposed for metabolomics. Our method differs 
from correlation-based networks (He, Chen and Evans, 2007; Wright et al., 1999; Bullmore and 
Sporns, 2009; Fromer et al., 2016) in that the latter tend to result in many dependencies that arise 
from undirected networks and face limited success at finding functional genes (Sullivan, Kendler, 
& Neale, 2003). However, the causal networks are directed graphs established in the recognition 
of the hierarchal structure of the biological systems, which provide better understanding of the 
regulatory patterns, as well as their causal interpretation. In addition, the causal network results 
into novel intervention targets and disease-associated genes with reproducible results. Studying of 
transcriptomic causal networks leads to the identification of differential gene regulation patterns, 
unveils the mechanisms that control the transcription of the SCZ-associated genes, and narrows 
down the search space for finding trans-regulatory elements to a subset of genes. Considering all 
together, the transcriptomic causal network facilitates efficient experimental study design for 
further analysis and provides a mechanistic understanding of disease processes (Pearl, 2000).  
In the present study, we used RNA-seq data from the dorsolateral prefrontal cortex of cases 
with SCZ and controls generated as part of the CommonMind Consortium, to build a 
transcriptomic causal network. Our study shows that genes whose transcription is highly regulated, 
i.e. they are highly connected in the network, are less likely to be affected by genetic variants. We 
identified 9 genes differentially regulated in SCZ cases versus controls: GABRA2, LRRTM2, 
PPM1E, SORT1, GNAL, ZNF69, RALGPS2, ZNF672, SNRNP48. Among these genes, GABRA2, 
LRRTM2, PPM1E have preferential transcription in human brain. 
  Mapping the SCZ-associated genes on the transcriptomic network, we defined modules of 
genes characterized by a high impact gene (“the hub”) on the transcription of downstream genes 
and then evaluated these effects with penalization and cross-validation methods. The observed 
pathways are made of a small subset of genes involving trans-regulatory interactions between 
genes in different chromosomes, as opposed the genetic variants that exert cis-regulatory effect on 
genes in the same chromosome. As a result, three of the identified hubs (NRXN3, TENM3 and 
MYH10) were essential genes for brain function since that are good targets for new therapeutic 
treatments since they control the transcription level of 15 genes, in both cases and controls. In 
addition, we discovered RNAF150, UNC5D, RTF, LMO7 and SEZ6L as novel SCZ-associated.  
 
 
 
Figure 1: Schematic representation of our approach. First it builds a causal network using 
transcriptomic, genotype and chromatin 3D contact data. Second, it identifies differential regulatory 
patterns and essential genes.  
 
 
Data 
RNA-seq  
Study sample: The RNA sequence (RNA-seq) data are from post-mortem dorsolateral 
prefrontal cortex which controls complex, higher-level cognitive and executive functions. These 
data are available in CommonMind Consortium (CMC; http://www.synapse.org/CMC). Following 
data normalization, 16,423 genes (based on Ensemble models) were expressed at levels sufficient 
for analysis, of which 14,222 were protein-encoding. Validation using PCR showed high 
correlation (r > 0.5) with normalized transcription from RNA-seq for the majority of genes 
assessed. Covariates for RNA integrity (RIN), library batch, institution (brain bank), diagnosis, 
age at death, genetic ancestry, post-mortem interval and sex together explained a substantial 
fraction (0.42) of the average variance of gene transcription and were thus employed to adjust the 
data for the analyses (Fromer et al., 2016). 
Genotype data 
Samples were genotyped on the Illumina Infinium HumanOmniExpressExome array 
(958,178 single-nucleotide polymorphisms, or SNPs). These genotypes were used to detect SNPs 
with influence on gene transcription, to estimate ancestry of the samples and to ensure sample 
identity across DNA and RNA experiments. The distribution of ethnicities shows Caucasian 
80.7%, African American 14.7%, Hispanic 7.7%, and East Asian 0.6%. To prevent the study from 
being confounded due to different ethnicities, we included 80.7% Caucasian (209 and 206 samples 
in SCZ control group respectively) in this study.  
Hi-C data 
The Hi-C libraries are constructed from mid-gestation developing human cerebral cortex 
during the peak of neurogenesis and migration from two major zones: the cortical and subcortical 
plate, consisting primarily of post-mitotic neurons and the germinal zone, containing primarily 
mitotically active neural progenitors (Won et al., 2016).  
 
Overview of the method 
Figure 1 provides a schematic representation of the approach, while each step is briefly 
explained in the following and detailed in method section.  
Step1: Building transcriptomic causal network 
We first extract genetic information in a new fashion considering that transcription is 
affected by genetic variations nearby genes (orientation, position, and distance) ( Yazdani, Mendez 
Giraldez, & Samiei, 2018). For each gene, we select genetic variants that mediate transcription of 
genes in cis-regulatory elements via both short- and long-range interactions using chip exome and 
high-resolution 3D maps of chromatin (Hi-C). We then adapt G-DAG algorithm (Yazdani et al., 
2016) for integrating our genetic variants and then built transcriptomic causal network established 
in Mendelian principles based on the fact that the genetic inherited variation is the cause of gene 
transcription not the other way around. We assess the quality of the fit by employing Hamming 
distance (Tsamardinos, Brown, & Aliferis, 2006) and test the stability of the network  using a 
backward selection techniques.  
Step 2: Identification of receptor, broadcaster, and mediator genes 
The casual network properties measure the genes impacts on the transcription network 
based on their out-degree and in-degree of a genes. The former refers to the number of downstream 
genes directly affected by a gene of interest, whereas the latter refers to the number of upstream 
genes that affect the corresponding target gene. Based on their connectivity, genes can be classified 
as broadcaster if they have a given out-degree and zero in-degree; receptors if they have a given 
in-degree and zero out-degree; and mediator if they have both non-zero out- and in-degrees. For 
instance, RAB30 in Figure 2A (closeup), has out-degree of 3, ZNF770, LCOR, MAP3K2 and 
MOB1B are the receptor genes and TYGO1, LRRC58, SESN3 are mediators. The effect of a gene 
can be propagated downstream until it reaches a receptor on a given path that is called pathway. 
Genes with high number of out-degree and long pathway across the network are called high impact 
genes or hubs. We further validated the impact of the genes in the network using penalized method 
and cross-validation techniques. 
Step 3: Module identification 
We define a module as a subnetwork that includes a high impact gene (i.e. the “hub”) and 
those genes that are highly influenced by the hub directly or indirectly. The boundaries of the 
modules are made of receptor genes that prevents the effect of the hub to be distributed beyond 
these genes. In order to identify modules related to SCZ, we mapped the SCZ-associated genes, 
according to liturature, on the transcriptomic network. Through further analyses, we assess the 
impact of the hub gene in the modules on  the transcription level of non-hub genes using linear 
regression model and cross-validation technique. 
Step 4: Identifying differential regulatory patterns, essential genes for brain function and 
novel genes putatively related to SCZ 
To estimate differential patterns between SCZ-cases and controls, we seek genes with high 
degree of connectivity in the networks whose loss of their connection might have significant effect 
on brain function. We exclude genes with only one upstream effector and search for differential 
patterns among the remaining gene subset.  
We next assessed the impact of the hub on the transcription of non-hub genes within each 
module, through linear prediction model and compare SCZ cases versus controls. The hubs that 
are good predictors for the transcription of downstream genes in both cases and controls are 
considered as essential for the normal brain function. The genes that are predicted differently 
between cases and controls correspond to the genes with alternation in their connectivity by 
acquiring or losing interaction in SCZ versus control groups. 
Given the list of SCZ-associated genes that are mapped in our causal network, we found 
new genes putatively related to SCZ and evaluated our results using conditional analysis assuming 
that the SCZ-associated genes are truly related to SCZ.   
 
Step5: Functional annotation of genes and broadcaster – receptor interactions 
To better understand the effect on transcription level exerted by one gene (broadcaster) 
onto another (receptor), we looked at different databases. Basic functional annotation and the 
proteins coded for the various genes provided from the UniProt KnowledgeBase (The UniProt 
Consortium, 2017). The latter was used to check for potential Transcription Factors or 
Transcription regulators. In many cases, the depicted regulatory relationships corresponded to 
genes in different chromosomes, i.e. typical trans-interactions, then we further checked the 
presence of non-coding RNAs overlapping any of the exons of the gene of interest according to 
the NCBI Genome Browser using NCBI (GRCh38.p13/p12) or Ensemble Genes definition 
(release 96), available through the Entrez Gene (Maglott, Ostell, Pruitt, & Tatusova, 2005). Since 
the reads from the RNA-seq experiment were aligned to a much older reference genome, hg19 
(Fromer et al., 2016) the counts matching both exons of a given gene and non-coding RNA 
according to the newer annotations, could well correspond to missannoated non-coding RNA, with 
potential trans-regulatory effect over distal genes. For each relevant gene within each of the 5 
described modules, we accounted for the level of expression in human brain and other relevant 
tissues according to the Human Protein Atlas (Uhlén et al., 2015), provided also by the Entrez 
Genes resource (Maglott et al., 2005). Given that it had been earlier determined that co-regulated 
proteins are likely to interact (Segal, Wang, & Koller, 2003), additional information about possible 
protein – protein interactions at different degree of evidences, from experiment to co-citations in 
PubMed abstracts was obtained from the STRING database (Szklarczyk et al., 2019).  
Results 
We generated 4,641 genetic variants from 958,178 SNPs and Hi-C data and identified the 
transcriptomic network over a set of 1,181 transcripts from a class of genes that includes the 
highest number of SCZ-associated genes according to Fromer et al. (2016). Among 4,641 genomic 
variants, 81 showed significant effect on gene transcription level.  The distributions of degrees (i.e. 
the sum of in- and out-degrees) for the genes influenced and for those not influenced by any genetic 
variants in the network are depicted in Figure 1B. Both histograms show similar distribution 
pattern, but the distribution without genetic variant is shifted towards degree ³ 1. Therefore, we 
conjectured that genes with high connectivity are less likely to be influenced by genomic variants 
(cis-regulation), thus their transcription is rather regulated directly or indirectly by other genes, 
mostly from different chromosomes (trans-regulation). Supplementary Table 1 lists the genes 
mapped influenced by genetic variants, together with in-/out-degrees. 
 We mapped the SCZ-associated genes on the identified transcriptomic network (blue 
colored nodes in Figure 2A), which revealed underlying relationships (pathways) among genes. 
To extract information from the transcriptomic causal networks, we measured the network 
properties and classified the genes as receptor, broadcaster, or mediators summarized in Figure 2C 
for SCZ-associated genes. Figure 2D clustered the SCZ associated genes based on type of studies 
that previously found the association (more details in Supplementary Table 2).
 Figure 2. A: Identified transcriptomic causal network and a closeup. Each node represents a gene. 
Genes associated with SCZ are depicted in blue. B: Distribution of the connectivity of the genes 
with genetic variants (left) and the genes without genetic variants (right).  C: Represents the in-
degree and out-degrees of genes associated with SCZ in the network. Single color bars in yellow or 
purple are corresponding to broadcaster and receptor genes respectively while bars with both colors 
are representing mediator genes. D: Venn diagram cluster SCZ-associated genes based on the type 
of studies that previously found their association (psych.cnv: Psychiatric study of copy number 
variation; SCZ.denovo.nonsyn: SCZ study of non-synonymous de novo mutations; SCZ.gwas: SCZ 
study of genome wide association studies; SCZ.denova.lof: SCZ study of Loss-of-function de novo 
mutations). 
 Differential gene regulatory patterns  
1- Loss of mediators  
We identified 9 mediator genes that lost their interactions with downstream genes in SCZ-
cases as compared to controls. Among these, 3 genes (GABRA2, LRRTM2, PPM1E) have biased 
expression in human brain with no or minimal expression in other human tissues (Supplementary 
Table 3). Figure 3A shows the exclusive effect of these three gene on their downstream genes in 
the network. The subnetworks of these mediators are depicted in Figure 3B which shows the 
calculated causal effect size of the transcription level on their downstream genes. 
 
Figure 3. A: Effect of the mediators exclusively expressed in brain on the downstream genes. The 
forest plot represents 95% confidence intervals of the effect size in downstream gene transcription 
by the different mediator gene, in red mean effect size for SCZ cases and in blue, mean effect size 
for controls. B: Upstream genes and downstream genes for the mediators (GABRA2, LRRTM2, 
PPM1E) and their causal effects. The arrows represent transcription activation (positive effect size). 
The line with capped end represents transcriptional repression (negative effect size). In cyan is the 
gene reported as SCZ-associated gene in previous studies. For all interactions, the effect size (Est) 
and standard deviation (Std) are shown. 
Using the STRING database (Szklarczyk et al., 2019), we found that the corresponding 
proteins GABRA2, LRRTM2, and PPM1E interact indirectly with the proteins encoded by the 
downstream genes in our network (Supplementary Table 4). Therefore, we believe that these 
proteins are extremely important for the normal brain function, since their corresponding genes 
(mediators) lost their effect on the downstream gene transcriptional regulation in SCZ-cases versus 
controls.  
Among the other 6 genes with loss of mediators (Figure 4), SORT1 and GNAL have the 
highest expression in brain; ZNF692 and RALGPS2 have highest expression in testis; ZNF672 and 
SNRNP48 are expressed in all tissues including brain. The corresponding proteins produced by all 
these genes interact directly/indirectly with the proteins encoded by the downstream genes in our 
network over control group (Supplementary Table 3). Therefore, based on our analysis, we believe 
these genes are implicated in SCZ, since these genes (mediators) lost their impact on the 
downstream gene transcriptional regulation in SCZ-cases versus controls. 
 
 
 
Figure 4. A: Effect of the mediator genes essential for normal brain functioning on the downstream 
genes. The forest plot represents 95% confidence intervals of the effect size in downstream gene 
transcription by the different mediator gene, in red mean effect size for SCZ cases and in blue, mean 
effect size for controls. B: Upstream genes and downstream genes for the mediators (ZNF672, 
ZNF692, SORT1, SNRNP48, GNAL, RALGPS2) and their causal effects. The arrows represent 
transcription activation (positive effect size). The line with capped end represents transcriptional 
repression (negative effect size). In cyan there are the genes reported as associated with SCZ in 
previous studies. For all interactions, the effect size (Est) and standard deviation (Std) are shown. 
 
2- Modules  
 
We identified several modules and predicted the amount of transcription of non-hub genes 
from the transcription level of the corresponding hub in both groups, SCZ cases and controls. In 
the following subsections, we described the modules summarized in Table 1 and depicted the 
modules as a sub-network in the corresponding figures for simplicity. For each module, the 
strength of the regulatory interactions in the network is represented by a heatmap of their 
corresponding p-values above a certain cutoff value, that is defined as the significance level of the 
likelihood for an edge to connect two genes (regulatory interaction) given the other genes in the 
network. Moreover, we discovered several differential regulatory patterns and two new genes 
putatively related to SCZ (Table 2) using prediction and conditional analysis.  
 
Table 1. Summary of the main features of the identified modules named after the gene acting as the 
hub; the number of genes in the module, the number of SCZ-associated genes, the number of genes 
influenced by the hub in the longest path, and the Gene Ontology annotation. 
 
 
Table 2. Novel SCZ associated genes and essential genes for brain functioning identified through 
regression and conditional analysis.  
 
TENM3-Module: TENM3 had previously associated to SCZ with impact on the 
transcription of 9 other genes downstream in our network (Supplementary, Table 5), 6 of which 
were known to be related to SCZ (Figure 5A, 5C). We explored the impact of TENM3, considered 
as the hub for this module, on non-hub genes within the module by predicting their transcription 
levels from TENM3 using cross-validation approach. Figure 5A represents the module sub-
network in controls. The prediction analysis resulted in a good performance in both SCZ and 
control groups (Figure 5B). Although TENM3 predicts slightly better the transcription level for the 
genes in the control as compared to the SCZ group, the result supports the interaction of hub with 
non-hub genes in both cases and controls. Therefore, TENM3 plays a key role at controlling the 
Module 
number Hub gene 
Number 
of genes 
Number of 
SCZ associated 
genes 
Number of 
genes in longest 
path 
Gene Ontology 
1 TENM3      10   7 4 Cellular Movement, reproductive system 
development & function, cardiovascular 
system development & function 
2 NRXN3 6 3 1 Gene Transcription, RNA damage & 
repair, RNA post-transcriptional 
modification 
3 MYH10  8 5 3 cellular development, cellular growth & 
proliferation, nervous system 
development & function 
3 PEX5L  
 
8 2 4 Cellular development, cellular Growth & 
proliferation, nervous system 
development & function 
Hypotheses 
Novel SCZ-associated genes Essential genes for brain function 
Genes Modules Essential gene SCZ-associated genes controlled by 
essential genes 
SEZ6L, RNF150 TENM3-Module TENM3  BTRC, RNF150, SEZ6L, GRIN3A, 
VAT1L, GRIA1, XKR4 
UNC5D            NRXN3-Module NRXN3 CNTNAP2, ARFGEF3 
RTF1                 MYH10-Module MYH10                                    ANK2, LMO7, LRRC4C, DLG2, RTF1, 
PTPRK 
FBXO32 PEX5L-Module PEX5L DLG2, STARD13 
transcription level of BTRC, RNF150, SEZ6L, GRIN3A, VAT1L, GRIA1, and XKR4 SCZ-
associated genes.  
The longest path in this module is TENM3à GRIN3Aà GRIA1à SORCS3à RNF150. 
All the genes in this pathway are associated with SCZ except RNF150. Therefore, we hypothesized 
that RNF150 is a SCZ-associated gene as well. This hypothesis is supported by the fact that another 
SCZ-associated gene from out of the module, FLRT2, directly affects RNF150 transcription. We 
predicted RNF150 transcription level based on the transcription of all three genes (SORCS3, 
FLRT2, SEZ6L) with direct impact on RNF150 using a penalization-regression model and cross-
validation (see methods for details). These three genes explained more than 70% of variation in 
RNF150 in both groups (Figure 5D) which agrees with our hypothesis since one of the two 
upstream genes of SEZ6L is SCZ-associated gene as well. Therefore, RNF150 can be a good 
candidate to study SCZ. 
 
 
Figure 5. A: TENM3-Module with SCZ-associated genes in cyan. B: Prediction of non-hub gene 
transcription levels based on transcription of the hub. This plot shows the average Pearson 
correlation coefficient between observed and predicted values for controls (blue) and SCZ 
individuals (red). C: Heatmap of the strength of the relationship between genes in the modules based 
on a p-value cut-off. D: Prediction of RNF150 transcription level in both SCZ and control groups 
using SEZ6L, FLRT2, SORCS3 transcription level as predictor.  
 
We used the Human Protein Atlas (HPA) to see the tissue-specific expression of genes in 
this module, both at mRNA and protein levels (Supplementary Figure 1). All the genes are 
expressed to some extent in human brain, although for some of them (SEZ6L, GRIN3A, XKR4 and 
SORCS3) there was no data available regarding the protein levels. The hub of the module, TENM3, 
showed high transcription and low protein level in human brain. It affected directly the 
transcription of two genes that are also highly transcribed in the brain (SEZ5L and GRIN3A) but 
no data is available for protein level. A search into the STRING database  for physical interactions 
between the proteins coded by those genes with evidence of expression  (GRIA1, BTRC, 
TCP11L1, RNF150) revealed the following interaction pairs: GRIA1– BTRC (meditated by 
DLG1), BTRC – ACACA (mediated by GSK3B) and BTRC – RAPGEF2 (mediated by 
CTNNB1). All these interactions are based on experimental evidences (see Supplementary Table 
6).  
NRXN3-Module: The NRXN3-Module (Figure 6A, C) includes 4 genes (ARFGEF3, 
HECW2, DLGAP1, CNTNAP2) whose transcription is directly influenced by NRXN3 hub 
(Supplementary Table 7). Even though the effect of NRXN3 itself does not propagate further within 
the network after one step, we believe it is an important gene since it encodes a member of a family 
of proteins that function in the nervous system as receptors and cell adhesion molecules [Ref]. 
NRXN3 is preferentially transcribed in brain according to HPA and has also been found associated 
with SCZ in a Genome Wide Association Study (GWAS) (Hu et al., 2013). This module unveils 
that MAS1 affects NRXN3 and FREM3 transcription, but the impact on NRXN3 is much higher 
(Figure 6C). NRXN3 exerts the effect of MAS1 into the system although FRM3 blocks the effect 
of MAS1. Interestingly, Gene Ontology analysis shows that all genes in the module except FRM3 
are related to “cancer, organismal injury and abnormalities, cellular development”. Hence, we 
included MAS1 in this module.  
We predicted gene transcription levels in both SCZ, and control groups based on NRXN3 
transcription. Figure 6B shows the average of the Pearson correlation coefficients between 
predicted and observed transcription values for SCZ (red) and control (blue) groups. The good 
agreement between predictions of downstream transcription levels in both, SCZ cases and controls, 
is an evidence of the essential role of NRXN3 in brain functioning. 
 Figure 6. A: NRXN3-Module with previously SCZ-associated genes in cyan. B: Prediction of non-
hub gene transcription levels based on transcription of the hub. The plot shows the average Pearson 
correlation coefficient between expected and predicted transcription. C: Heatmap of the strength of 
the relationship between genes in the modules based on the significance of their association in the 
network. D: Prediction UNC5D transcription level in both SCZ and control groups using GRIN2A, 
PCDH19, GRM5, CNTNAP2 transcription levels.  
 
The highest impact of NRXN3 is on CNTNAP2 gene (Figure 6A, C) which is influenced by 4 genes 
(UNC5D, CNTNAP2, SLC4A8, CAMTA1 and STS) from outside the module. Among these 4 genes, 
UNC5D is the most relevant to our study, since its transcription directly influenced 3 SCZ-
associated genes (PCDH19, GRM5, CNTNAP2) and is also influenced by a SCZ-associated gene 
(GRIN2A). Therefore, we strongly hypothesized that UNC5D is a gene related to SCZ given that 
PCDH19, GRM5, and CNTNAP2 are associated with SCZ. We tested this hypothesis by predicting 
the transcription level of UNC5D as a linear outcome of the genes with direct connection (GRIN2A, 
PCDH19, GRM5, CNTNAP2). As it can be seen in Figure 6D, the good predictions in both, cases 
and controls, supports our hypothesis. 
 
According to the HPA, NRXN3 is moderately expressed in the brain at both  mRNA and 
protein levels (Supplementary Figure 2). Among 4 genes that are directly affected by the hub, 
CNTNAP2 and HECW2 show also high protein and mRNA levels in the brain. Although, there is 
no data available for DLGAP1 and ARFGEF3 at protein level in the, DLGAP1 is one of the genes 
with highest mRNA level in the module. Searching for protein-protein interactions in STRING 
database, we found the following interactions: NRXN3 – DLGAP1; NRXN3 – CNTNAP2 
(meditated by DLG); GRIN2A – PCHD19; GRIN2A – CNTNAP2; GRIN2A – GRM5. More 
details can be found in Supplementary Table 8.  
 
MYH10-Module: MYH10 is associated with SCZ that influences the transcription of 7 
other genes in the network (Figure 7A and Supplementary Table 9) and its transcription is 
influenced by two upstream genes (ADAM23 and CHD6). In this module all the genes except those 
influenced by MYH10 through LMO7 pathway are associated to SCZ. MYH10 and LMO7 in turn, 
are in the longest and strongest path in this module (Figure 7A, C). The impact of the hub on the 
downstream genes are investigated using prediction model. The transcription of all target genes in 
the module can be predicted from the transcription activity of the MHYH10 in SCZ-cases and 
controls, except for the furthest-related (HMG20A) gene to the hub (Figure 7B). Consequently, we 
hypothesized that LMO7 and RTF1 are also associated with SCZ. We assessed the effect of LMO7 
on RTF1 to see if this influence is due to MYH10 that is a SCZ-associated gene or on the contrary, 
it is due to ROCK2 gene. Using conditional analysis, we calculated the exclusive effect in regard 
to MYH10, ROCK2 and both (Figure 7D).  Hence, LOM7 and RTF1 both are associated with SCZ. 
Furthermore, we conclude that MYH10 has a key role in regulating the transcription of ANK2, 
LMO7, LRRC4C, DLG2, RTF1, PTPRK genes. 
 
 
 
 
 
 
 
                      
Figure 7. A: MYH10-Module with SCZ-associated genes in cyan. B: Prediction of non-hub gene 
transcription levels based on transcription of the hub. The plot shows the average Pearson correlation 
coefficient between expected and predicted transcription. C: Heatmap of the strength of the 
relationship between genes in the modules based on the significance of their association in the 
network. D: Summary-result of assessing the effect of LMO7 on RTF1 using conditional analysis in 
4 different scenarios. 
 
All the genes in this module are expressed significantly in brain, at both mRNA and protein levels 
(Supplementary, Table 10). STRING database showed the protein interactions of MYH10 - ANK2 
(mediated by MYH9 and SPTAN1), ANK2 - DLG2 (mediated by NRCAM or NFASC), LRRC4C 
- DLG2 and MYH10 - RTF1 (mediated by MYH9 and CDC5L). MYH10 protein and its upstream 
donor in our network ADAM23, which shows medium protein level in brain according to HPA, 
interact through MYL3 mediator (Supplementary, Table 11). In addition, gene ontology analysis 
categorized all genes in MYH10-Module with similar Function, “cell-to-cell signaling and 
interaction, nervous system development and function, cell morphology”. 
 
PEX5L-Module: PEX5L has strong significant impact on two genes associated with SCZ 
(STARD13 and DLG2) (Figure 8A, C and Table 12 in Supplementary) making PEX5L a good 
target for SCZ studies. The effect of PEX5L is very strong upon the genes of the first interaction 
shell and it decreases along the path through successive indirect interactions (Figure 8C). PEX5L 
lost its indirect effect on FBXO32, ZBTB43, and TGOLN2 genes in SCZ-cases as compared to 
controls since it shows poor prediction performance for these genes for SCZ-cases (Figure 8B).  
   
               
Figure 8. A: PEX5L-Module with a SCZ-associated in cyan. B: Prediction of non-hub gene 
transcription levels based on transcription of the hub. The plot shows the average Pearson correlation 
coefficient between expected and predicted transcription. C: Heatmap of the strength of the 
relationship between genes in the modules based on the significance of their association in the 
network. 
 
DLG2 is a receptor at the edge of the PEX5L- and MYH10-Modules. Although the strength 
of connection in the former module is higher than the latter, both hubs are good predictors for 
DLG2 transcription level. We used protein-protein interaction data from STRING database and 
observed that DLG2 has stronger interaction with MYH10 protein through ANK2 (Supplementary 
Table 13). Therefore, we consider DGL2 belongs to the MYH10-Module at the protein – protein 
interaction level, but to both modules at transcriptional regulation level.  
 
Figure 8A also shows that the direction of PALM2 interaction over PEX5L could not be 
identified through this analysis. While PALM2 is out of the module, at the edge of the absolute 
network and has no genetic variants associated with it, we believe that PALM2 transcription may 
be regulated by other genes that are not included in this study. All genes in this module share the 
same function related to “Cellular development, cellular Growth and proliferation, nervous system 
development and function” according to the Gene Ontology.  
 
 
Discussion: 
The effect of gene expression profile alterations on human health require to be investigated 
in relation with other genes in a particular tissue. In this study, we focused on understanding the 
gene regulatory pattern in human brain in the context of schizophrenia (SCZ). We introduced a 
novel approach for building transcriptomic causal network and for comparing the gene regulatory 
pattern between SCZ cases and controls. The transcription of a gene may be affected by genetic 
variants in cis-regulatory regions, but it can also be mediated by transcribed genes in trans. Using 
these observations, we integrated exome chip, Hi-C, RNA-seq data and built the transcriptional-
causal network. Interestingly, genes with fewer connections are more likely to be affected by 
genetic variants than those highly connected in our network, but the latter are more often found 
regulated by or regulating other genes in trans. We also identified essential genes for brain 
function, whose transcription regulation does not change between cases and controls, using linear 
regression and cross-validation approaches. Additionally, we identified genes that are 
differentially regulated in SCZ cases.  
Three genes, GABRA2, LRRTM2 and PPM1E that are differentially regulated in individuals 
diagnosed with SCZ are also preferentially expressed in human brain. All these genes are related 
to synapse, which have been hypothesized to underlie altered neuronal function in complex 
neuropsychiatric disorders (Wang, Christian, Song, & Ming, 2018). In particular, GABRA2 is 
believed to be a component of the hetero-pentameric receptor for GABA, the major inhibitory 
neurotransmitter in the brain. Consequently, it plays an important role in the formation of 
functional inhibitory GABAergic synapses in addition to mediating synaptic inhibition as a 
GABA-gated ion channel (based on homology). LRRTM2 is involved in the development and 
maintenance of the excitatory synapse in vertebrates, regulates surface expression of AMPA 
receptors, and instructs the development of functional glutamate release sites. PPM1E encodes 
protein phosphatase that inactivates multifunctional CaM kinases, whose activation can affect 
many downstream pathways controlling a variety of cellular functions (Swulius & Waxham, 
2008).  
Our analysis shows differential regulation of GNAL between SCZ and control groups. In 
our network, GNAL that encodes a stimulatory G protein alpha subunit is a mediator between two 
SCZ drug targets (CHRM3 and CHRNA7). The protein coded by the upstream gene CHRM3 is 
targeted by antipsychotic drugs against schizophrenia and bipolar disorder but causes insulin 
dysregulation that may precede diabetes. CHRNA7 as downstream gene of GNAL is also 
considered a promising drug target for treatment of cognitive dysfunction in schizophrenia and 
improves memory and executive functions in patients and healthy individuals. However, clinical 
trials with pro-cognitive drugs are challenged by large inter-individual response variations. This 
differential regulatory pattern suggests that GNAL can be an alternative SCZ drug target since it 
encodes a G protein alpha subunit that is widely expressed in the central nervous system.  
The following four genes PEX5L, TENM3, NRXN3, MYH10 are essential for brain function 
since they have high impacts on several genes in both SCZ and control groups. PEX5L has biased 
expression in brain. The corresponding PEX5L protein is believed to work as accessory subunit of 
hyperpolarization-activated cyclic nucleotide-gated channels, regulating their cell-surface 
expression and cAMP dependence (The UniProt Consortium, 2017). PEX5L exerts a significant 
effect directly on the transcription of three genes: DGL2, STARD13 and LRRTM3. While the first 
two had been previously linked to SCZ, LRRTM3 has also biased expression in brain. Homologous 
proteins to LRRTM3 are involved in the development and maintenance of the vertebrate nervous 
system (The UniProt Consortium, 2017). Furthermore, among all downstream genes of PEX5L, 
FBXO32 shows the highest difference in regulation between cases and controls. This differential 
pattern is supported by the fact that FBXO32 promotes neuronal protein homeostasis through 
coordinating autophagy/lysosome-mediated protein turnover with the ubiquitin–proteasome 
system (Murdoch et al., 2016). 
TENM3 encodes a protein that translocates in the nucleus, regulating the transcriptional 
activity of genes related to neurite growth and cell adhesion [wiki from pfam]. This is clearly in 
agreement with our results since TENM3 strongly affects multiple genes in our network. In 
addition, it has been shown that its homologous protein establishes the neuron connectivity in the 
mouse brain (Berns, DeNardo, Pederick, & Luo, 2018). NRXN3 protein is involved in synaptic 
plasticity (Kelai et al., 2008). Moreover, among the four genes directly influenced by NRXN3, 
three of them (DLGAP1, DLGAP1, CNTNAP2) are related to synaptic plasticity as well (Toro et 
al., 2010; Ullman, Smith-Hicks, Desai, & Stafstrom, 2018).	Thus, it makes sense to consider all 
five genes associated with synaptic dysfunction, which is a causal factor for neuropsychiatric 
disorders including SCZ. MYH10 gene is important for the normal development and function of 
dendritic spines ( Zhang, Webb, Asmussen, Niu, & Horwitz, 2005) (Rex et al., 2010)(Ryu et al., 
2006)(Hodges, Newell-Litwa, Asmussen, Vicente-Manzanares, & Horwitz, 2011). 
 We conclude that genetic variation in the context of schizophrenia works as cis-regulatory 
elements for genes that are not so much involved in trans-regulatory interactions. This property 
may just be general of gene regulatory networks. Our method provided the regulatory context for 
essential genes in the brain. Besides, the proposed approach was also able to generate new sets of 
genes putatively associated with SCZ that are differentially regulated in cases. To the best of our 
knowledge, the latter will allow for the first time, the design of further experiments to target those 
relevant genes, either by editing them, or drug targeting, without disrupting essential pathways for 
normal brain function. Altogether this work presents a significant step towards the rational 
understanding of the genetic mechanisms of schizophrenia and pave the way for designing new 
and more selective treatments that minimize undesired secondary effects. 
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